RRM2B and neoplasm: While head and neck cancers carried a lower frequency of amplifications in RRM2B (similar to few other tumor types in Figure 1A), we chose this tumor type because of the clinical significance of TP53 alteration status to HNSCCs (Zhou et al., 2016) and the known regulation of RRM2B by p53.